noom glp 1 microdose Launches GLP-1 Program, Including Medication and Microhabits Program 🚨 INTRODUCING: Noom Proactive Health

Link to full post: GLP-1 Drugs, Digital Health & Obesity Trends in 2026Overweight and obesity are driving a booming digital health market through telehealth, wearables, and new pharma-to-consumer models.I've been reporting on this space in my #Trends report since March 2024two years ago (Navigating Obesity Care in the Digital Age)

Rybelsus and Farxiga treat Type 2 diabetes, but one has more approved uses, among other differences, such as cost and side effects.

Manifestations can vary from isolated liver enzyme elevation to fulminant hepatic failure

GLP-1s like Ozempic, Wegovy, and Mounjaro have gained a lot of media attention for weight loss, but how do these weight-loss injections work

Learn how weight loss drug coverage is changing for Medicare GLP-1 prescriptions in 2026 and how Absolute Best Insurance can help review options.

Aims/hypothesis Unimolecular peptides targeting the receptors for glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP) and glucagon (GCG) have been shown to improve glycaemic management in both mice and humans